Bangladesh Pharmaceuticals and Healthcare Report Q2 2012Business Monitor International
March 20, 2012
83 Pages - SKU: BMI3816743
More Prescription Drugs reports by Business Monitor International
Brazil Pharmaceuticals and Healthcare Report Q3 2013 by Business Monitor International
BMI View: The Brazilian government has become increasingly proactive in supporting localpharmaceutical industry. At a time when the public sector is trying to balance increasing ...
Kuwait Pharmaceuticals and Healthcare Report Q3 2013 by Business Monitor International
BMI View: Opportunities in Kuwait's healthcare and pharmaceuticals market are limited, given its smallpopulation, limited domestic drug production and the high proportion of expatriates. The ...
Italy Pharmaceuticals and Healthcare Report Q3 2013 by Business Monitor International
BMI View: The sharp drop in public pharmaceutical expenditure in Italy in 2012 to a level below that of2001 does not bode well for drugmakers ...
Tanzania Pharmaceuticals and Healthcare Report Q3 2013 by Business Monitor InternationalSee all reports like this >>
BMI View: Increased longevity in developed markets translates into an increased demand for aged carehealthcare services and medicines. However, in emerging markets such as Tanzania, ...
More Bangladesh Prescription Drugs reports
Bangladesh Pharmaceuticals and Healthcare Report Q3 2013 by Business Monitor International
BMI View: While Bangladesh has a substantial population of 152mn people, annual per capita expenditureon healthcare is very modest at just US$28. Despite expected economic ...
Antibiotics Market in Bangladesh to 2016 by Global Research & Data Services
This market research report offers a perspective on the actual market situation, trends and future outlook for antibiotics in Bangladesh. The study provides essential market ...
Bangladesh Pharmaceuticals and Healthcare Report Q3 2012 by Business Monitor International
BMI View: The Bangladeshi government will need to address the impact of high inflation and the strain of the weak taka on medicine prices in ...
The Pharmaceutical Market: Bangladesh by Espicom Healthcare IntelligenceSee all reports like this >>
Espicom’s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of ...
More Bangladesh reports
D&B Country RiskLine Report: Bangladesh by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: Bangladesh by Dun & Bradstreet Inc.See all reports like this >>
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
We can help you find what you need. Call us or write us:
Need help in your search?
- Hospitals & Clinics
- Country Overviews
- Life Sciences
- Country Overviews
- Manufacturing, Packaging & Detailing
- Prescription Drugs
Prescription Drugs Reports